Burden of Disease and Cost of Illness of Triple-Negative Breast Cancer in Portugal.

ABSTRACT:

Background

Triple-negative breast cancer accounts for 15% of all breast cancer cases, and it has a lower survival rate and higher incidence of early recurrence, particularly during the first 10 years after diagnosis.

Objective

This study aimed to estimate the cost and burden of triple-negative breast cancer among the female population in 2019 in Portugal from a societal perspective.

Methods

The prevalence of triple-negative breast cancer was calculated using a cumulative incidence model on the basis of national epidemiological data. The burden of disease was expressed as disability-adjusted life years, including the years lost due to disability and years of life lost. Healthcare resource utilization was quantified with input from an expert panel, and costs were estima

SUBMITTER: Silva J 

PROVIDER: S-EPMC12037440 | biostudies-literature | 2025 May

REPOSITORIES: biostudies-literature